Buy Steroids Online

пятница, 15 марта 2013 г.

Drug manufacturers and anti-doping officers unite their efforts


Nowadays a lot of pharmaceutical companies are ready to cooperate with anti-doping officers in their fight against administration of forbidden medications in sports. It sounds strange but this is the reality. In fact, if you review the fate of EPO, you can comprehend why drug manufacturers agree to support efforts of anti-doping officers. EPO is really an effectual remedy for treatment of anemia. A lot of individuals with anemia that have applied EPO have been treated. But what do you think while hearing about this medicine? Almost each individual associates this remedy only with doping in sports. This medication has been abused by Lance Armstrong that has cheated the whole world. Thus, EPO is associated only with cheating, disgrace, etc. Looking at this situation, pharmaceutical companies try to “defend” their medications from the similar fate. That’s why they work together with anti-doping officers.
However some pharmaceutical companies began to collaborate with anti-doping officers earlier, sometimes there were certain problems between them. Anti-doping officers criticized certain drug manufacturers for their links to doping.
Nowadays relations between anti-doping officials and pharmaceutical companies are closer. Pharmaceutical companies share detailed information about new medications with anti-doping agencies. It is valuable information for development of detection tests for these preparations. While anti-doping agencies learn how drugs are manufactured, how they pass into body, how they work in the body, they can elaborate more effectual tests for these drugs.
For example, the pharmaceutical company Roche that elaborated the medication CERA helped anti-doping officers to introduce a detection test for it. Later other pharmaceutical companies followed the example of Roche. The pharmaceutical company GlaxoSmithKline went so far, as it sponsored an anti-doping lab during London Olympics.
While relations between anti-doping agencies and big pharmaceutical companies become closer, smaller drug manufacturers begin to cooperate with anti-doping officers as well. While earlier drug manufacturers haven’t wanted to discuss about their links to anti-doping officers openly, nowadays they don’t fear to announce about this aspect.

Комментариев нет:

Отправить комментарий